SOURCE: Fresh Start Private Management, Inc.

Fresh Start Private Management,  Inc.

January 21, 2014 08:00 ET

Fresh Start Private Management, Inc. Announces Appearance on the Emmy® Award-Winning Show, THE DOCTORS

LOS ANGELES, CA--(Marketwired - Jan 21, 2014) - Fresh Start Private Management, Inc. (OTCQB: CEYY) announces that Jeremy Miller, star of the former hit TV show Growing Pains and Dr. Fallieras, medical director at Start Fresh Recovery will appear on the Emmy® Award-winning nationally syndicated daytime talk show, THE DOCTORS. The episode is scheduled to air tomorrow, January 22nd (check local listings). Jeremy is a successful graduate of the company's revolutionary alcohol treatment program that includes a specially formulated surgical implant of the drug Naltrexone that significantly reduces physical cravings for alcohol, coupled with a private coaching program specifically tailored to address the mental aspect of the addiction. Jeremy now works as a patient advocate at Start Fresh Recovery which uses the program developed by Fresh Start Private. They will be on the show to discuss how the program is being used to treat a patient named Todd who will also appear as a guest. The show will feature Todd's life before he entered the program, followed by his actual implant procedure. Then viewers will witness how his life has dramatically changed when he appears to the live studio audience. A clip from the episode will be available after airing at

"I can't tell you how proud we are of Todd's courage to tell his story on national television. That takes guts, and hopefully his consent to air footage of his rock bottom to the world, followed by his amazing transformation will give hope to countless others," said Brady Granier, COO of Fresh Start Private.

About Fresh Start Private (Soon to be BioCorRx, Inc.)

Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a highly effective program consisting of two components used by alcohol addiction clinics in the US. Clinic reports show that the treatment program has an 85% success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opiate antagonist that significantly reduces physical cravings for alcohol, into the body. The second component of the program developed by Fresh Start Private is a one on one coaching program specifically tailored for the treatment of alcoholism. For more information on CEYY, visit

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

Contact Information

  • Investor Relations Contact:
    Maximum Performance Advisors, Inc.